1. Home
  2. SCOR vs MXCT Comparison

SCOR vs MXCT Comparison

Compare SCOR & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

N/A

Current Price

$6.45

Market Cap

112.4M

ML Signal

N/A

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.02

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCOR
MXCT
Founded
1999
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.4M
93.0M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
SCOR
MXCT
Price
$6.45
$1.02
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
9.7K
973.4K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
127.37
N/A
EPS
N/A
N/A
Revenue
$403,549,000.00
$33,026,000.00
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.30
$18.50
P/E Ratio
$1.55
N/A
Revenue Growth
1.02
N/A
52 Week Low
$4.39
$0.64
52 Week High
$10.18
$2.40

Technical Indicators

Market Signals
Indicator
SCOR
MXCT
Relative Strength Index (RSI) 40.29 61.92
Support Level $6.22 $0.77
Resistance Level $7.07 $1.16
Average True Range (ATR) 0.38 0.08
MACD -0.07 0.01
Stochastic Oscillator 20.38 66.76

Price Performance

Historical Comparison
SCOR
MXCT

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: